Related Experiment Videos
Improved O-serotyping method for Serratia marcescens
1Central Public Health Laboratory, London, England.
Journal of Clinical Microbiology
|December 1, 1989
Summary
A new dot immunoassay offers more accurate lipopolysaccharide (LPS) antigen identification for Serratia marcescens strains than traditional agglutination tests. This method identified previously unknown LPS antigens and improved serotype specificity.
Area of Science:
- Microbiology
- Immunology
- Bacteriology
Background:
- Traditional agglutination tests for Serratia marcescens serotyping are unreliable.
- Some O serotypes are not accurately defined by lipopolysaccharide (LPS) O antigens.
- A more specific method for LPS antigen identification is needed.
Purpose of the Study:
- To develop and validate a highly specific dot enzyme immunoassay for Serratia marcescens LPS antigen identification.
- To compare the accuracy of the dot immunoassay with conventional agglutination tests.
- To characterize the LPS antigen profiles of clinical Serratia marcescens strains.
Main Methods:
- A dot enzyme immunoassay was developed for high-specificity LPS detection.
- 104 distinct clinical strains of Serratia marcescens were tested.
- Results were compared with traditional agglutination tests using O antisera.
Main Results:
- The dot immunoassay identified known LPS antigens in only 36 strains, with limited overlap between existing serotypes.
- Two novel LPS antigens, S1254 and S3255, were discovered.
- Prodigiosin production correlated with specific serotypes and LPS phenotypes.
- The dot immunoassay demonstrated superior accuracy for LPS antigen identification compared to agglutination.
Conclusions:
- The dot enzyme immunoassay is a more accurate method for Serratia marcescens serotyping than agglutination tests.
- This assay can identify novel LPS antigens and refine serotype classifications.
- Accurate LPS antigen identification is crucial for understanding Serratia marcescens epidemiology and characteristics.